IL115225A0 - Preparations containing estrogen compounds for use in the treatment of osteoporosis - Google Patents

Preparations containing estrogen compounds for use in the treatment of osteoporosis

Info

Publication number
IL115225A0
IL115225A0 IL11522595A IL11522595A IL115225A0 IL 115225 A0 IL115225 A0 IL 115225A0 IL 11522595 A IL11522595 A IL 11522595A IL 11522595 A IL11522595 A IL 11522595A IL 115225 A0 IL115225 A0 IL 115225A0
Authority
IL
Israel
Prior art keywords
osteoporosis
treatment
preparations containing
estrogen compounds
containing estrogen
Prior art date
Application number
IL11522595A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL115225A0 publication Critical patent/IL115225A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
IL11522595A 1994-09-09 1995-09-08 Preparations containing estrogen compounds for use in the treatment of osteoporosis IL115225A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30392694A 1994-09-09 1994-09-09

Publications (1)

Publication Number Publication Date
IL115225A0 true IL115225A0 (en) 1995-12-31

Family

ID=23174293

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11522595A IL115225A0 (en) 1994-09-09 1995-09-08 Preparations containing estrogen compounds for use in the treatment of osteoporosis

Country Status (8)

Country Link
EP (1) EP0804202A4 (fr)
JP (1) JP2001503728A (fr)
KR (1) KR970705397A (fr)
CN (1) CN1158569A (fr)
AU (1) AU3674895A (fr)
CA (1) CA2199250A1 (fr)
IL (1) IL115225A0 (fr)
WO (1) WO1996007416A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545635A (en) * 1995-05-23 1996-08-13 Eli Lilly And Company Inhibiting bone loss with equilenin
SE9702401D0 (sv) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
CN101355959B (zh) 2005-11-10 2013-02-27 密歇根理工大学管理委员会 黑熊甲状旁腺素和使用黑熊甲状旁腺素的方法
EP2509996A1 (fr) 2009-12-07 2012-10-17 Michigan Technological University Hormone parathyroïde de l'ours noir et ses procédés d'utilisation
WO2015057836A2 (fr) * 2013-10-15 2015-04-23 The Trustees Of Columbia University In The City Of New York Hormone parathyroïdienne anabolique osseuse et analogues de protéine apparentée à l'hormone parathyroïdienne

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118667A (en) * 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
TW303299B (fr) * 1993-07-22 1997-04-21 Lilly Co Eli

Also Published As

Publication number Publication date
EP0804202A1 (fr) 1997-11-05
JP2001503728A (ja) 2001-03-21
WO1996007416A1 (fr) 1996-03-14
KR970705397A (ko) 1997-10-09
CN1158569A (zh) 1997-09-03
EP0804202A4 (fr) 1999-01-13
CA2199250A1 (fr) 1996-03-14
AU3674895A (en) 1996-03-27

Similar Documents

Publication Publication Date Title
GB9407135D0 (en) Treatment of osteoporosis
EG24222A (en) Spiro-azabicyclic compounds useful in therapy
IL112455A0 (en) Combination treatment for osteoporosis
ZA988886B (en) Formulation for treatment of osteoporosis
GB9204354D0 (en) Compounds for medicinal use
IL113248A0 (en) Use of alpha - 1c specific compounds
ZA951322B (en) Process for the preparation of polyalkyl-1-oxa-diazaspiro-decane compounds
GB9423868D0 (en) Compounds for use in medicine
GB9413451D0 (en) Container for medical waste
GB9416467D0 (en) Compounds for use in medicine
GB9413935D0 (en) Use of maramyl peptide compounds
GB9424694D0 (en) Compounds for use in medicine
IL115224A0 (en) Preparations for use in the treatment of osteoporosis
IL115225A0 (en) Preparations containing estrogen compounds for use in the treatment of osteoporosis
HUP9903852A3 (en) Process for the preparation of contrast agents
HUP0100542A3 (en) Progestogen and antiprogestogen containing kit, process for its preparation and use of the compounds for the preparation of contraseptives
IL115223A0 (en) Preparation containing antiresorptive compounds for use in the treatment of osteoporosis
GB9219776D0 (en) New compounds for use in the treatment of cancer
GB9401599D0 (en) Vessel for containing surgical waste
IL115853A (en) Aryloxycycloalkenyl and aryloxyiminocyclo-alkenylhydroxyureas and pharmaceutical compositions containing these compounds
EP0460690A3 (en) Use of phenolsulfophthaline derivatives for the treatment of osteoporosis
GB9625449D0 (en) Compounds for use in medicine
GB9501142D0 (en) Compounds for use in medicine
GB9416316D0 (en) Compounds for use in treatment of carcinomas
GB9504627D0 (en) Compounds for use in therapy